Frost & Sullivan
Cost cutting in healthcare expanding markets for generic, biogeneric products
Published in Health Insurance Law Weekly, October 17th, 2004
There has also been a conscious move in developed societies to increase the use of generic and biogeneric products for containing healthcare expenses.
New analysis from Frost & Sullivan, "World Generics and Biogenerics Markets," reveals the global generics and biogenerics markets revenue totaled $35.4 billion in 2003 and is projected to reach $71.9 billion in 2010.
In the United States, health plan providers are offering incentives for plan members to use generic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
More Articles from Health Insurance Law Weekly
- Bristol-Myers Squibb
Settlement awards $11.3 million to U.S. government for Medicaid expenses - Communicable Disease
Proposal would force treatment of communicable diseases - Healthcare Coverage
Georgia Medicare recipients to get more choices - Healthcare Coverage
High hospital charges are a major factor in skyrocketing premiums - Healthcare Coverage
Highmark decreases premiums, adds benefits - Medical Fraud
California attorney general charges 20 dentists with fraud - More from this issue of Health Insurance Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
